IN THE KNOW: Club drugs | Inquirer News

IN THE KNOW: Club drugs

07:21 AM March 25, 2019

Club drugs have become popular among teenagers who attend “raves” at bars, nightclubs, concerts and parties because they are perceived to enhance energy, endurance, sociability and to cause sexual arousal.

The US National Institute on Drug Abuse identified social drugs as MDMA (ecstasy), rohypnol, ketamine and gamma hydroxybutyrate (GHB).

Clinical effects of ecstasy include feelings of self-confidence, depression and increase in sexual pleasure.

Article continues after this advertisement

It is in tablet or capsule form and can be ingested orally, crushed and snorted, dissolved or injected.

FEATURED STORIES

Rohypnol, which is used to treat insomnia, lessens anxiety, inhibition and muscular tension, but higher doses could result in anterograde amnesia, lack of muscular control or loss of consciousness.

It is available only in tablet form and typically ingested orally.

Article continues after this advertisement

High dose of ketamine, which is mostly used in veterinary practice, could cause hallucination and visual distortion.

Article continues after this advertisement

It is in liquid or powder form and added to items to be smoked or dissolved in drink.

Article continues after this advertisement

Excessive GHB could lead to unconsciousness, agitation, enhanced libido, vomiting or muscle spasms.

Used to treat cataplexy associated with narcolepsy (sleep disorder), GHB is liquid and often mixed with alcohol or beverage to amplify its effects.

Article continues after this advertisement

Common toxic effects of club drugs are fatigue, hypertension, dizziness, hallucinations, seizures, coma and death. —INQUIRER RESEARCH
SOURCES: US NATIONAL INSTITUTE ON DRUG ABUSE AND INDIAN JOURNAL OF MEDICAL RESEARCH

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.